🇺🇸 FDA
Patent

US 10287340

Anti-HIV domain antibodies and method of making and using same

granted A61KA61K38/1774A61K39/42

Quick answer

US patent 10287340 (Anti-HIV domain antibodies and method of making and using same) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K38/1774, A61K39/42, A61K47/6841, A61P